Rare diseases
Investigational molecules
Locations
60 Hampshire Street, 02139-1548, United States
Relay Therapeutics Inc. supports clinical research in advanced solid tumors with a focus on cancers driven by PIK3CA alterations, including disease settings where the mutation is identified in blood and/or tumor tissue.
The sponsor’s oncology portfolio centers on targeted treatment approaches for molecularly defined breast cancer and other solid malignancies.
Relay Therapeutics Inc. runs clinical trials in conditions such as Breast cancer, Breast cancer metastatic, Hormone receptor positive HER2 negative breast cancer, Lymphatic malformation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
